Brain endothelial TAK1 and NEMO safeguard the neurovascular unit

Journal of Experimental Medicine

Volumn 212, Issue 10, 2015, Pages 1529-1549

  Ridder, Dirk A ^a   Wenzel, Jan ^a,b   Müller, Kristin ^a   Töllner, Kathrin ^c,d   Tong, Xin Kang ^e   Assmann, Julian C ^a   Stroobants, Stijn ^f   Weber, Tobias ^a   Niturad, Cristina ^a   Fischer, Lisanne ^a   Lembrich, Beate ^a   Wolburg, Hartwig ^g   Grand'Maison, Marilyn ^e   Papadopoulos, Panayiota ^e   Korpos, Eva ^h   Truchetet, Francois ⁱ   Rades, Dirk ^a   Sorokin, Lydia M ^h   Schmidt Supprian, Marc ^j   Bedell, Barry J ^e   Pasparakis, Manolis ^k   Balschun, Detlef ^f   D'Hooge, Rudi ^f   Löscher, Wolfgang ^c,d   Hame, Edith ^e   Schwaninger, Markus ^a,b   more..

^a UNIVERSITY OF LÜBECK   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^d CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^h UNIVERSITY OF MÜNSTER   (Germany)

ⁱ Centre Hospitalier Regional Metz Thionville   (France)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^k UNIVERSITY OF COLOGNE   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

OCCLUDIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TIGHT JUNCTION PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; I KAPPA B KINASE; IKBKB PROTEIN, MOUSE; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; NEMO PROTEIN, MOUSE; OCLN PROTEIN, MOUSE; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CAPILLARY ENDOTHELIUM; BRAIN EDEMA; BRAIN FUNCTION; CONTROLLED STUDY; DEATH; ENDOTHELIUM CELL; FEMALE; GENETIC DISORDER; INCONTINENTIA PIGMENTI; INFLAMMATION; MICROVASCULATURE; MOUSE; NEUROLOGIC DISEASE; NEUROVASCULAR COUPLING; NONHUMAN; OXIDATIVE STRESS; PERICYTE; PRIORITY JOURNAL; PROTEIN STABILITY; SEIZURE; ANIMAL; BRAIN; BRAIN CIRCULATION; C57BL MOUSE; EPILEPSY; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE; VASCULARIZATION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CEREBROVASCULAR CIRCULATION; ENDOTHELIAL CELLS; EPILEPSY; FEMALE; I-KAPPA B KINASE; INCONTINENTIA PIGMENTI; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAP KINASE KINASE KINASES; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OCCLUDIN; TNF RECEPTOR-ASSOCIATED FACTOR 6; TRANSCRIPTION FACTOR RELA;

EID: 84951728678     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20150165     Document Type: Article

References (81)

1. Abe, S., A. Okumura, S. Hamano, M. Tanaka, T. Shiihara, K. Aizaki, T. Tsuru, Y. Toribe, H. Arai, and T. Shimizu. 2011. Early infantile manifestations of incontinentia pigmenti mimicking acute encephalopathy. Brain Dev. 33: 28-34. http://dx.doi.org/10.1016/j.braindev.2010.04.002
2. Alvarez, J.I., T. Katayama, and A. Prat. 2013. Glial influence on the blood brain barrier. Glia. 61: 1939-1958. http://dx.doi.org/10.1002/glia .22575
3. Argaw, A.T., Y. Zhang, B.J. Snyder, M.L. Zhao, N. Kopp, S.C. Lee, C.S. Raine, C.F. Brosnan, and G.R. John. 2006. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J. Immunol. 177: 5574-5584. http://dx.doi.org/10.4049/jimmunol .177.8.5574
4. Avrahami, E., S. Harel, U. Jurgenson, and D.F. Cohn. 1985. Computed tomographic demonstration of brain changes in incontinentia pigmenti. Am. J. Dis. Child. 139:372-374.
5. Bachevalier, F., C. Marchal, M.P. Di Cesare, A. Antunes, and F. Truchetet. 2003. Atteinte neurologique létale au cours d'une incontinentia pigmenti. Ann. Dermatol. Venereol. 130:1139-1142.
6. Bangerter, N.K., B.A. Hargreaves, S.S. Vasanawala, J.M. Pauly, G.E. Gold, and D.G. Nishimura. 2004. Analysis of multiple-acquisition SSFP. Magn. Reson. Med. 51: 1038-1047. http://dx.doi.org/10.1002/mrm .20052
7. Beard, R.S. Jr., R.J. Haines, K.Y. Wu, J.J. Reynolds, S.M. Davis, J.E. Elliott, N.L. Malinin, V. Chatterjee, B.J. Cha, M.H. Wu, and S.Y. Yuan. 2014. Nonmuscle Mlck is required for β-catenin- and FoxO1-dependent downregulation of Cldn5 in IL-1β-mediated barrier dysfunction in brain endothelial cells. J. Cell Sci. 127: 1840-1853. http://dx.doi.org/10.1242/jcs.144550
8. Bell, R.D., E.A. Winkler, I. Singh, A.P. Sagare, R. Deane, Z. Wu, D.M. Holtzman, C. Betsholtz, A. Armulik, J. Sallstrom, et al. 2012. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 485: 512-516. http://dx.doi.org/10.1038/nature11087
9. Boulanger, L.M. 2009. Immune proteins in brain development and synaptic plasticity. Neuron. 64: 93-109. http://dx.doi.org/10.1016/j.neuron.2009.09.001
10. Brown, W.R. 2010. A review of string vessels or collapsed, empty basement membrane tubes. J. Alzheimers Dis. 21: 725-739. http://dx.doi.org/ 10.3233/JAD-2010-100219
11. Carman, A.J., J.H. Mills, A. Krenz, D.G. Kim, and M.S. Bynoe. 2011. Adenosine receptor signaling modulates permeability of the bloodbrain barrier. J. Neurosci. 31: 13272-13280. http://dx.doi.org/10.1523/ JNEUROSCI.3337-11.2011
12. Catrysse, L., L. Vereecke, R. Beyaert, and G. van Loo. 2014. A20 in inflammation and autoimmunity. Trends Immunol. 35: 22-31. http://dx.doi.org/ 10.1016/j.it.2013.10.005
13. Chatkupt, S., A.O. Gozo, L.J. Wolansky, and S. Sun. 1993. Characteristic MR findings in a neonate with incontinentia pigmenti. AJR Am. J. Roentgenol. 160: 372-374. http://dx.doi.org/10.2214/ajr.160.2.8424354
14. Chen, Y.H., M. Chang, and B.L. Davidson. 2009. Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy. Nat. Med. 15: 1215-1218. http://dx.doi.org/10.1038/nm.2025
15. Clark, K., S. Nanda, and P. Cohen. 2013. Molecular control of the NEMO family of ubiquitin-binding proteins. Nat. Rev. Mol. Cell Biol. 14: 673-685. http://dx.doi.org/10.1038/nrm3644
16. Collins, D.L., P. Neelin, T.M. Peters, and A.C. Evans. 1994. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 18: 192-205. http://dx.doi.org/10.1097/ 00004728-199403000-00005
17. Cummins, P.M. 2012. Occludin: one protein, many forms. Mol. Cell. Biol. 32: 242-250. http://dx.doi.org/10.1128/MCB.06029-11
18. De Lorenzi, R., R. Gareus, S. Fengler, and M. Pasparakis. 2009. GFP-p65 knock-in mice as a tool to study NF-kappaB dynamics in vivo. Genesis. 47: 323-329. http://dx.doi.org/10.1002/dvg.20468
19. Dondelinger, Y., M.A. Aguileta, V. Goossens, C. Dubuisson, S. Grootjans, E. Dejardin, P. Vandenabeele, and M.J. Bertrand. 2013. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ. 20: 1381-1392. http://dx.doi.org/10.1038/cdd.2013.94
20. Erickson, M.A., and W.A. Banks. 2013. Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J. Cereb. Blood Flow Metab. 33: 1500-1513. http://dx.doi.org/10.1038/jcbfm.2013.135
21. Everett, R.S., M.K. Vanhook, N. Barozzi, I. Toth, and L.G. Johnson. 2006. Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide. Mol. Pharmacol. 69: 492-500. http://dx.doi.org/10.1124/mol.105.017251
22. Fonov, V., A.C. Evans, K. Botteron, C.R. Almli, R.C. McKinstry, and D.L. Collins. Brain Development Cooperative Group. 2011. Unbiased average age-appropriate atlases for pediatric studies. Neuroimage. 54: 313-327. http://dx.doi.org/10.1016/j.neuroimage.2010.07.033
23. Gareus, R., E. Kotsaki, S. Xanthoulea, I. van der Made, M.J.J. Gijbels, R. Kardakaris, A. Polykratis, G. Kollias, M.P.J. de Winther, and M. Pasparakis. 2008. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab. 8: 372-383. http://dx.doi.org/10.1016/j.cmet.2008.08.016
24. Girouard, H., and C. Iadecola. 2006. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J. Appl. Physiol. 100: 328-335. http://dx.doi.org/10.1152/japplphysiol.00966.2005
25. Goldberg, M.F.M.D. 2004. The skin is not the predominant problem in incontinentia pigmenti. Arch. Dermatol. 140: 748-750. http://dx.doi.org/ 10.1001/archderm.140.6.748
26. Goldmann, T., P. Wieghofer, P.F. Müller, Y. Wolf, D. Varol, S. Yona, S.M. Brendecke, K. Kierdorf, O. Staszewski, M. Datta, et al. 2013. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat. Neurosci. 16: 1618-1626. http://dx.doi.org/10.1038/nn.3531
27. Grand'maison, M., S.P. Zehntner, M.K. Ho, F. Hébert, A. Wood, F. Carbonell, A.P. Zijdenbos, E. Hamel, and B.J. Bedell. 2013. Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease. Neurobiol. Dis. 54: 59-67. http://dx.doi.org/10.1016/j.nbd.2013.02.005
28. Gregor, M.F., and G.S. Hotamisligil. 2011. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29: 415-445. http://dx.doi.org/10.1146/annurevimmunol-031210-101322
29. Hébert, F., M. Grand'maison, M.K. Ho, J.P. Lerch, E. Hamel, and B.J. Bedell. 2013. Cortical atrophy and hypoperfusion in a transgenic mouse model of Alzheimer's disease. Neurobiol. Aging. 34: 1644-1652. http://dx.doi.org/10.1016/j.neurobiolaging.2012.11.022
30. Hennel, S.J., P.G. Ekert, J.J. Volpe, and T.E. Inder. 2003. Insights into the pathogenesis of cerebral lesions in incontinentia pigmenti. Pediatr. Neurol. 29: 148-150. http://dx.doi.org/10.1016/S0887-8994(03)00150-4
31. Hirase, T., J.M. Staddon, M. Saitou, Y. Ando-Akatsuka, M. Itoh, M. Furuse, K. Fujimoto, S. Tsukita, and L.L. Rubin. 1997. Occludin as a possible determinant of tight junction permeability in endothelial cells. J. Cell Sci. 110:1603-1613.
32. Ivens, S., D. Kaufer, L.P. Flores, I. Bechmann, D. Zumsteg, O. Tomkins, E. Seiffert, U. Heinemann, and A. Friedman. 2007. TGF-beta receptormediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain. 130: 535-547. http://dx.doi.org/10.1093/brain/awl317
33. Jacob, A., B. Hack, P. Chen, R.J. Quigg, and J.J. Alexander. 2011. C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κB. J. Neurochem. 119: 1041-1051. http://dx.doi.org/10.1111/j.1471-4159.2011.07490.x
34. Keller, A., A. Westenberger, M.J. Sobrido, M. García-Murias, A. Domingo, R.L. Sears, R.R. Lemos, A. Ordoñez-Ugalde, G. Nicolas, J.E. da Cunha, et al. 2013. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat. Genet. 45: 1077-1082. http://dx.doi.org/10.1038/ng.2723
35. Kielland, A., L.M. Camassa, G. Døhlen, L.A. Munthe, R. Blomhoff, M. Amiry-Moghaddam, and H. Carlsen. 2012. NF-κB activity in perinatal brain during infectious and hypoxic-ischemic insults revealed by a reporter mouse. Brain Pathol. 22: 499-510. http://dx.doi.org/10.1111/j.1750-3639.2011.00548.x
36. Kisseleva, T., L. Song, M. Vorontchikhina, N. Feirt, J. Kitajewski, and C. Schindler. 2006. NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer. J. Clin. Invest. 116: 2955-2963. http://dx.doi.org/10.1172/JCI27392
37. Kolodziej, L.E., J.P. Lodolce, J.E. Chang, J.R. Schneider, W.A. Grimm, S.J. Bartulis, X. Zhu, J.S. Messer, S.F. Murphy, N. Reddy, et al. 2011. TNFAIP3 maintains intestinal barrier function and supports epithelial cell tight junctions. PLoS ONE. 6:e26352. http://dx.doi.org/10.1371/journal.pone.0026352
38. Lau, J.C., J.P. Lerch, J.G. Sled, R.M. Henkelman, A.C. Evans, and B.J. Bedell. 2008. Longitudinal neuroanatomical changes determined by deformationbased morphometry in a mouse model of Alzheimer's disease. Neuroimage. 42: 19-27. http://dx.doi.org/10.1016/j.neuroimage.2008.04.252
39. Lomaga, M.A., W.-C. Yeh, I. Sarosi, G.S. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufman, et al. 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13: 1015-1024. http://dx.doi.org/10.1101/gad.13.8.1015
40. Madisen, L., T.A. Zwingman, S.M. Sunkin, S.W. Oh, H.A. Zariwala, H. Gu, L.L. Ng, R.D. Palmiter, M.J. Hawrylycz, A.R. Jones, et al. 2010. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13: 133-140. http://dx.doi.org/ 10.1038/nn.2467
41. Maingay-de Groof, F., M.H. Lequin, D.W. Roofthooft, A.P. Oranje, I.F. de Coo, L.A. Bok, P.J. van der Spek, G.M. Mancini, and P.P. Govaert. 2008. Extensive cerebral infarction in the newborn due to incontinentia pigmenti. Eur. J. Paediatr. Neurol. 12: 284-289. http://dx.doi.org/10.1016/j.ejpn.2007.09.001
42. Makris, C., V.L. Godfrey, G. Krähn-Senftleben, T. Takahashi, J.L. Roberts, T. Schwarz, L. Feng, R.S. Johnson, and M. Karin. 2000. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol. Cell. 5: 969-979. http://dx.doi.org/10.1016/S1097-2765(00)80262-2
43. Matullo, C.M., K.J. O'Regan, H. Hensley, M. Curtis, and G.F. Rall. 2010. Lymphocytic choriomeningitis virus-induced mortality in mice is triggered by edema and brain herniation. J. Virol. 84: 312-320. http://dx .doi.org/10.1128/JVI.00727-09
44. Meuwissen, M.E., and G.M. Mancini. 2012. Neurological findings in incontinentia pigmenti; a review. Eur. J. Med. Genet. 55: 323-331. http://dx.doi.org/10.1016/j.ejmg.2012.04.007
45. Morioka, S., M. Inagaki, Y. Komatsu, Y. Mishina, K. Matsumoto, and J. Ninomiya-Tsuji. 2012. TAK1 kinase signaling regulates embryonic angiogenesis by modulating endothelial cell survival and migration. Blood. 120: 3846-3857. http://dx.doi.org/10.1182/blood-2012-03-416198
46. Naert, A., I. Gantois, A. Laeremans, S. Vreysen, G. Van den Bergh, L. Arckens, Z. Callaerts-Vegh, and R. D'Hooge. 2013. Behavioural alterations relevant to developmental brain disorders in mice with neonatally induced ventral hippocampal lesions. Brain Res. Bull. 94: 71-81. http://dx.doi.org/ 10.1016/j.brainresbull.2013.01.008
47. O'Donnell, M.A., H. Hase, D. Legarda, and A.T. Ting. 2012. NEMO inhibits programmed necrosis in an NFκB-independent manner by restraining RIP1. PLoS ONE. 7:e41238. http://dx.doi.org/10.1371/ journal.pone.0041238
48. Obermeier, B., R. Daneman, and R.M. Ransohoff. 2013. Development, maintenance and disruption of the blood-brain barrier. Nat. Med. 19: 1584-1596. http://dx.doi.org/10.1038/nm.3407
49. Østergaard, L., S.N. Jespersen, K. Mouridsen, I.K. Mikkelsen, K.Y. Jonsdottír, A. Tietze, J.U. Blicher, R. Aamand, N. Hjort, N.K. Iversen, et al. 2013. The role of the cerebral capillaries in acute ischemic stroke: the extended penumbra model. J. Cereb. Blood Flow Metab. 33: 635-648. http://dx.doi .org/10.1038/jcbfm.2013.18
50. Polykratis, A., G. van Loo, S. Xanthoulea, M. Hellmich, and M. Pasparakis. 2012. Conditional targeting of tumor necrosis factor receptor-associated factor 6 reveals opposing functions of Toll-like receptor signaling in endothelial and myeloid cells in a mouse model of atherosclerosis. Circulation. 126: 1739-1751. http://dx.doi.org/10.1161/CIRCULATIONAHA.112.100339
51. Ridder, D.A., M.F. Lang, S. Salinin, J.P. Röderer, M. Struss, C. Maser-Gluth, and M. Schwaninger. 2011. TAK1 in brain endothelial cells mediates fever and lethargy. J. Exp. Med. 208: 2615-2623. http://dx.doi.org/ 10.1084/jem.20110398
52. Roy, A., and D.C. Hooper. 2007. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J. Virol. 81: 7993-7998. http://dx.doi.org/10.1128/JVI.00710-07
53. Saitou, M., M. Furuse, H. Sasaki, J.D. Schulzke, M. Fromm, H. Takano, T. Noda, and S. Tsukita. 2000. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol. Biol. Cell. 11: 4131-4142. http://dx.doi.org/10.1091/mbc.11.12.4131
54. Sakurai, H. 2012. Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol. Sci. 33: 522-530. http://dx.doi.org/10.1016/j .tips.2012.06.007
55. Sasaki, Y., E. Derudder, E. Hobeika, R. Pelanda, M. Reth, K. Rajewsky, and M. Schmidt-Supprian. 2006. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity. 24: 729-739. http://dx .doi.org/10.1016/j.immuni.2006.04.005
56. Sato, S., H. Sanjo, K. Takeda, J. Ninomiya-Tsuji, M. Yamamoto, T. Kawai, K. Matsumoto, O. Takeuchi, and S. Akira. 2005. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6: 1087-1095. http://dx.doi.org/10.1038/ni1255
57. Schmidt-Supprian, M., W. Bloch, G. Courtois, K. Addicks, A. Israël, K. Rajewsky, and M. Pasparakis. 2000. NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol. Cell. 5: 981-992. http://dx.doi.org/ 10.1016/S1097-2765(00)80263-4
58. Schoch, H.J., S. Fischer, and H.H. Marti. 2002. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain. 125: 2549-2557. http://dx.doi.org/10.1093/brain/awf257
59. Schwenk, F., U. Baron, and K. Rajewsky. 1995. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23: 5080-5081. http://dx.doi.org/10.1093/nar/23.24.5080
60. Seiffert, E., J.P. Dreier, S. Ivens, I. Bechmann, O. Tomkins, U. Heinemann, and A. Friedman. 2004. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J. Neurosci. 24: 7829-7836. http://dx.doi.org/10.1523/JNEUROSCI.1751-04.2004
61. Sled, J.G., A.P. Zijdenbos, and A.C. Evans. 1998. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging. 17: 87-97. http://dx.doi.org/10.1109/42.668698
62. Sonkusare, S.K., A.D. Bonev, J. Ledoux, W. Liedtke, M.I. Kotlikoff, T.J. Heppner, D.C. Hill-Eubanks, and M.T. Nelson. 2012. Elementary Ca2+ signals through endothelial TRPV4 channels regulate vascular function. Science. 336: 597-601. http://dx.doi.org/10.1126/science.1216283
63. Sorokin, L.M., F. Pausch, M. Frieser, S. Kröger, E. Ohage, and R. Deutzmann. 1997. Developmental regulation of the laminin alpha5 chain suggests a role in epithelial and endothelial cell maturation. Dev. Biol. 189: 285-300. http://dx.doi.org/10.1006/dbio.1997.8668
64. Taccone, F.S., F. Su, C. Pierrakos, X. He, S. James, O. Dewitte, J.L. Vincent, and D. De Backer. 2010. Cerebral microcirculation is impaired during sepsis:an experimental study. Crit. Care. 14:R140. http://dx.doi.org/10.1186/cc9205
65. Tong, X.K., N. Nicolakakis, A. Kocharyan, and E. Hamel. 2005. Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease. J. Neurosci. 25: 11165-11174. http://dx.doi.org/10.1523/JNEUROSCI.4031-05.2005
66. Tong, X.K., N. Nicolakakis, P. Fernandes, B. Ongali, J. Brouillette, R. Quirion, and E. Hamel. 2009. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Neurobiol. Dis. 35: 406-414. http://dx.doi.org/10.1016/j.nbd.2009.06.003
67. Tong, X.K., C. Lecrux, P. Rosa-Neto, and E. Hamel. 2012. Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits. J. Neurosci. 32: 4705-4715. http://dx.doi.org/10.1523/ JNEUROSCI.0169-12.2012
68. Tripathi, A.K., W. Sha, V. Shulaev, M.F. Stins, and D.J. Sullivan Jr. 2009. Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. Blood. 114: 4243-4252. http://dx.doi.org/10.1182/blood-2009-06-226415
69. Tronche, F., C. Kellendonk, O. Kretz, P. Gass, K. Anlag, P.C. Orban, R. Bock, R. Klein, and G. Schütz. 1999. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23: 99-103. http://dx.doi.org/10.1038/12703
70. Tsao, N., H.P. Hsu, C.M. Wu, C.C. Liu, and H.Y. Lei. 2001. Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis. J. Med. Microbiol. 50:812-821.
71. Van der Jeugd, A., T. Ahmed, S. Burnouf, K. Belarbi, M. Hamdame, M.-E. Grosjean, S. Humez, D. Balschun, D. Blum, L. Buée, and R. D'Hooge. 2011. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Neurobiol. Learn. Mem. 95: 296-304. http://dx.doi.org/10.1016/j.nlm.2010.12.005
72. van Loo, G., R. De Lorenzi, H. Schmidt, M. Huth, A. Mildner, M. Schmidt-Supprian, H. Lassmann, M.R. Prinz, and M. Pasparakis. 2006. Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat. Immunol. 7: 954-961. http://dx.doi.org/10.1038/ni1372
73. Vanlangenakker, N., T. Vanden Berghe, P. Bogaert, B. Laukens, K. Zobel, K. Deshayes, D. Vucic, S. Fulda, P. Vandenabeele, and M.J. Bertrand. 2011. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ. 18: 656-665. http://dx.doi.org/10.1038/cdd.2010.138
74. Wu, C., F. Ivars, P. Anderson, R. Hallmann, D. Vestweber, P. Nilsson, H. Robenek, K. Tryggvason, J. Song, E. Korpos, et al. 2009. Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat. Med. 15: 519-527. http://dx.doi.org/10.1038/nm.1957
75. Xiao, Y., H. Li, J. Zhang, A. Volk, S. Zhang, W. Wei, S. Zhang, P. Breslin, and J. Zhang. 2011. TNF-α/Fas-RIP-1-induced cell death signaling separates murine hematopoietic stem cells/progenitors into 2 distinct populations. Blood. 118: 6057-6067. http://dx.doi.org/10.1182/blood-2011-06-359448
76. Ye, X., J. Ding, X. Zhou, G. Chen, and S.F. Liu. 2008. Divergent roles of endothelial NF-kappaB in multiple organ injury and bacterial clearance in mouse models of sepsis. J. Exp. Med. 205: 1303-1315. http://dx.doi .org/10.1084/jem.20071393
77. Zhang, X., J.A. Winkles, M.C. Gongora, R. Polavarapu, J.S. Michaelson, K. Hahm, L. Burkly, M. Friedman, X.J. Li, and M. Yepes. 2007. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia. J. Cereb. Blood Flow Metab. 27: 534-544. http://dx.doi.org/10.1038/sj.jcbfm.9600368
78. Zhang, L., P. Papadopoulos, and E. Hamel. 2013. Endothelial TRPV4 channels mediate dilation of cerebral arteries: impairment and recovery in cerebrovascular pathologies related to Alzheimer's disease. Br. J. Pharmacol. 170: 661-670. http://dx.doi.org/10.1111/bph.12315
79. Zhu, W., N.R. London, C.C. Gibson, C.T. Davis, Z. Tong, L.K. Sorensen, D.S. Shi, J. Guo, M.C. Smith, A.H. Grossmann, et al. 2012. Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability. Nature. 492: 252-255. http://dx.doi.org/10.1038/ nature11603
80. Zlokovic, B.V. 2008. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 57: 178-201. http://dx.doi.org/10.1016/j.neuron.2008.01.003
81. Zlokovic, B.V. 2011. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12: 723-738. http://dx.doi.org/10.1038/nrn3114